Influence of tumour size on uptake of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model

Ítems similars

• Biodistribution and pharmacokinetics of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
  per: Harrington, K J, et al.
  Publicat: (2000)
• Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model
  per: Harrington, K J, et al.
  Publicat: (2004)
• Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
  per: Rowlinson-Busza, G., et al.
  Publicat: (1995)
• Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma.
  per: Vaage, J., et al.
  Publicat: (1997)
• Pharmacokinetics and Dosimetry of (111)In/(188)Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models
  per: Lin, Yi-Yu, et al.
  Publicat: (2011)